🔎 Trials Near Me

Utama › Jangkitan Saluran Pernafasan › Texas

Kajian klinikal Jangkitan Saluran Pernafasan di Texas

5 kajian untuk Jangkitan Saluran Pernafasan sedang mencari peserta di lokasi di Texas.

Bandar di Texas

Teks kajian rasmi (Bahasa Inggeris)

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

  • Research Site, Amarillo
  • Research Site, Dallas
  • Research Site, El Paso
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05624450

A Study of COVID-19 Vaccine(s) in Children and Adults

  • Cedar Health Research, Dallas
  • Cedar Health Research, Euless
  • DM Clinical Research-Cyfair, Houston
  • dan 1 lagi
Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan
Umur 5 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07798648

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

  • Zenos Clinical Research, Dallas
  • Southwest Family Medicine Associates, Dallas
  • Southwest Mind and Body Care, Dallas
  • dan 9 lagi
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06679140

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

  • Zenos Clinical Research, Dallas
  • Baylor Scott & White Health - Center for Advanced Heart and Lung Disease, Dallas
  • Baylor Scott & White Research Institute - Clinical Trials Office, Dallas
  • dan 8 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07013474

An Adjunct Test Distinguishing Bacterial From Viral Etiology Improves Resource Utilization and Efficiency in the ED.

  • The University of Texas Health Science Center at Houston, Houston
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Jan 2026 · NCT06070688

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.